Clifford Capital Partners LLC Raises Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Clifford Capital Partners LLC raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 58.4% during the 2nd quarter, Holdings Channel reports. The firm owned 803,204 shares of the pharmacy operator’s stock after buying an additional 296,135 shares during the quarter. Walgreens Boots Alliance comprises 2.1% of Clifford Capital Partners LLC’s portfolio, making the stock its 29th largest holding. Clifford Capital Partners LLC’s holdings in Walgreens Boots Alliance were worth $9,715,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. Atlas Brown Inc. boosted its position in Walgreens Boots Alliance by 1.8% in the 1st quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock worth $685,000 after purchasing an additional 550 shares in the last quarter. Shilanski & Associates Inc. grew its position in Walgreens Boots Alliance by 5.3% during the first quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock valued at $256,000 after buying an additional 591 shares during the period. First Trust Direct Indexing L.P. increased its holdings in Walgreens Boots Alliance by 1.9% in the first quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock valued at $696,000 after buying an additional 597 shares in the last quarter. Buckley Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 2.1% in the first quarter. Buckley Wealth Management LLC now owns 37,335 shares of the pharmacy operator’s stock worth $810,000 after acquiring an additional 785 shares during the period. Finally, FinTrust Capital Advisors LLC grew its position in shares of Walgreens Boots Alliance by 60.4% during the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 802 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $8.70 on Wednesday. The stock has a fifty day simple moving average of $9.90 and a 200-day simple moving average of $14.07. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The stock has a market cap of $7.51 billion, a PE ratio of -1.29, a P/E/G ratio of 1.03 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a twelve month low of $8.22 and a twelve month high of $27.05.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 11.49%. The ex-dividend date of this dividend was Wednesday, August 21st. Walgreens Boots Alliance’s payout ratio is -14.84%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. TD Cowen reduced their price target on Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a report on Thursday, September 12th. Barclays decreased their target price on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 23rd. Royal Bank of Canada cut their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a report on Tuesday, July 2nd. JPMorgan Chase & Co. decreased their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. Finally, Bank of America cut their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.